Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: A population study

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Panayiotou, Andrie G ^a,b   Griffin, Maura ^c   Kouis, Panayiotis ^a   Tyllis, Theodosis ^d   Georgiou, Niki ^d   Bond, Dawn ^c   Nicolaides, Andrew N ^b,c,d,e  

^a CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

^b Cyprus Cardiovascular Disease Educational and Research Trust   (Cyprus)

^c Vascular Noninvasive Screening and Diagnostic Centre   (United Kingdom)

^d Vascular Screening and Diagnostic Centre Nicosia   (Cyprus)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerotic plaques; Carotid; Femoral; IMT; Metabolic syndrome; Metabolic syndrome components; Plaque area

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ANALYTICAL PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY BIFURCATION; CAROTID ARTERY PLAQUE; CEREBROVASCULAR DISEASE; CHOLESTEROL EDUCATION PROGRAM; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYPRUS; DISEASE ASSOCIATION; EDUCATION PROGRAM; FAMILY HISTORY; FEMALE; FEMORAL ARTERY PLAQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; ULTRASOUND;

EID: 84883152620     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-44     Document Type: Article

References (53)

1. Metabolic syndrome pandemic. Grundy SM, Arterioscler Thromb Vasc Biol 2008 28 4 629 636 10.1161/ATVBAHA.107.151092 18174459
2. Metabolic syndrome-a new worldwide definition. A consensus statement from the international diabetes federation. Alberti K, Zimmet P, Shaw J, Diabetic Med 2006 23 5 469 480 10.1111/j.1464-5491.2006.01858.x 16681555
3. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J, James WPT, Loria CM, Smith SC, Circulation 2009 120 16 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
4. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Bayturan O, Tuzcu EM, Lavoie A, Hu T, Wolski K, Schoenhagen P, Kapadia S, Nissen SE, Nicholls SJ, Arch Intern Med 2010 170 5 478 10.1001/archinternmed.2009.551 20212186
5. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W, Berenson GS, Stein JH, J Am Coll Cardiol 2005 46 3 457 463 10.1016/j.jacc.2005.04.046 16053958
6. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ, J Am Coll Cardiol 2010 56 14 1113 1132 10.1016/j.jacc.2010.05.034 20863953
7. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk. Smith SR, Obesity 2012 14 S6 128S 134S
8. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM, J Am Coll Cardiol 2007 49 4 403 414 10.1016/j.jacc.2006.09.032 17258085
9. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Malik S, Wong ND, Franklin SS, Kamath TV, Gilbert J, Pio JR, Williams GR, Circulation 2004 110 10 1245 1250 10.1161/01.CIR.0000140677.20606.0E 15326067
10. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX, Am J Epidemiol 1997 146 6 483 494 10.1093/oxfordjournals. aje.a009302 9290509
11. Prediction of clinical cardiovascular events with carotid intima-media thickness. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M, Circulation 2007 115 4 459 467 10.1161/CIRCULATIONAHA.106.628875 17242284
12. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE, Circulation 1997 96 5 1432 1437 10.1161/01.CIR.96.5.1432 9315528
13. Toward clinical applications of carotid ultrasound: intima-media thickness, plaque area, and three-dimensional phenotypes. Spence JD, Rundek T, Ultrasound and Carotid Bifurcation Atherosclerosis London: Springer 2012 431 448
14. Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Spence JD, Am J Cardiol 2002 89 4 10 15 10.1016/S0002-9149(01)02327-X
15. Carotid plaque area a tool for targeting and evaluating vascular preventive therapy. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T, Stroke 2002 33 12 2916 2922 10.1161/01.STR.0000042207.16156.B9 12468791
16. Carotid and femoral arterial wall changes and the prevalence of clinical cardiovascular disease. Griffin M, Nicolaides A, Tyllis T, Georgiou N, Martin RM, Bond D, Panayiotou A, Tziakouri C, Doré CJ, Fessas C, Vasc Med 2009 14 3 227 232 10.1177/1358863X08101542 19651672
17. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Schmidt C, Fagerberg B, Hulthe J, Atherosclerosis 2005 181 1 125 10.1016/j.atherosclerosis. 2004.12.034 15939063
18. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Held C, Hjemdahl P, Eriksson S, Björkander I, Forslund L, Rehnqvist N, Eur Heart J 2001 22 1 62 72 10.1053/euhj.1999.2006 11133211
19. Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries. Vaudo G, Marchesi S, Siepi D, Brozzetti M, Mannarino MR, Pirro M, Schillaci G, Ciuffetti G, Lupattelli G, Mannarino E, Metab Clin Exp 2007 56 4 541 546 10.1016/j.metabol.2006.11.016 17379014
20. Relationship of the metabolic syndrome to carotid ultrasound traits. Pollex RL, Al-Shali KZ, House AA, Spence JD, Fenster A, Mamakeesick M, Zinman B, Harris SB, Hanley AJ, Hegele RA, Cardiovasc Ultrasound 2006 4 28 10.1186/1476-7120-4-28 16827932
21. Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Hassinen M, Komulainen P, Lakka TA, Vaisanen SB, Haapala I, Gylling H, Alen M, Schmidt-Trucksass A, Nissinen A, Rauramaa R, Arch Intern Med 2006 166 4 444 16505265
22. The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. Rundek T, White H, BodenAlbala B, Jin Z, Elkind MS, Sacco RL, Journal of the cardiometabolic syndrome 2007 2 1 24 29 10.1111/j.1559-4564.2007.06358.x 17684455
23. Leukocyte telomere length is associated with measures of subclinical atherosclerosis. Panayiotou A, Nicolaides A, Griffin M, Tyllis T, Georgiou N, Bond D, Martin R, Hoppensteadt D, Fareed J, Humphries S, Atherosclerosis 2010 211 1 176 181 10.1016/j.atherosclerosis.2010.01.037 20219198
24. Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers. Cena H, Tesone A, Niniano R, Cerveri I, Roggi C, Turconi G, Diabetology & metabolic syndrome 2013 5 1 28 10.1186/1758-5996-5-28 23960029
25. Prevalence and gender distribution of the metabolic syndrome. Ogbera AO, Diabetol Metab Syndr 2010 2 1 4 10.1186/1758-5996-2-4 20180980
26. Alcohol consumption and metabolic syndrome. Fujita N, Takei Y, Hepatology Research 2011 41 4 287 295 10.1111/j.1872-034X.2011.00787.x 21426447
27. The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects the three-city study. Empana J, Zureik M, Gariepy J, Courbon D, Dartigues JF, Ritchie K, Tzourio C, Alperovitch A, Ducimetiere P, Stroke 2007 38 3 893 899 10.1161/01.STR.0000257983.62530.75 17272758
28. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Ahluwalia N, Drouet L, Ruidavets J, Perret B, Amar J, Boccalon H, Hanaire-Broutin H, Ferrieres J, Atherosclerosis 2006 186 2 345 353 10.1016/j.atherosclerosis.2005.07.021 16129441
29. A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants. Adolphe A, Cook LS, Huang X, Mayo Clin Proc 2009 84 3 221 228 10.4065/84.3.221 19252108
30. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. Fadini GP, Coracina A, Inchiostro S, Tiengo A, Avogaro A, De Kreutzenberg SV, Eur J Cardiovasc Prev Rehabil 2008 15 2 190 196 10.1097/HJR.0b013e3282f17bc3 18391647
31. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort study-CVD. Xu L, Jiang CQ, Lam TH, Lin JM, Yue XJ, Cheng KK, Liu B, Jin YL, Zhang WS, Thomas GN, Clin Endocrinol (Oxf) 2010 73 2 181 188
32. The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromso study. Herder M, Arntzen KA, Johnsen SH, Mathiesen EB, Cardiovasc Diabetol 2012 11 1 77 10.1186/1475-2840-11-77 22738646
33. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C, Azen SP, Ann Intern Med 1998 128 4 262 269 10.7326/0003-4819-128-4-199802150- 00002 9471928
34. The risk of the metabolic syndrome on carotid thickness and stiffness: sex and age specific effects. Lin H, Liu C, Liao Y, Lin R, Chen C, Juo SH, Atherosclerosis 2010 210 1 155 159 10.1016/j.atherosclerosis.2009.11.027 20035939
35. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B, Stroke 2005 36 6 1212 1217 10.1161/01.STR.0000166196.31227.91 15890992
36. Impact of metabolic syndrome on the progression of intima-media thickening in Japanese-a follow-up study. Matoba Y, Inoguchi T, Suzuki S, Nasu S, Hashimoto T, Yanase T, Nawata H, Takayanagi R, Diabetes Res Clin Pract 2009 86 3 50 e53 10.1016/j.diabres.2009.09.013 19818522
37. Ultrasound markers that describe plaques are more sensitive than mean intima-media thickness in patients with familial hypercholesterolemia. Ershova AI, Balakhonova TV, Meshkov AN, Rozhkova TA, Boytsov SA, Ultrasound Med Biol 2012 38 3 417 422 10.1016/j.ultrasmedbio.2011.11.014 22261515
38. Treating arteries instead of risk factors a paradigm change in management of atherosclerosis. Spence JD, Hackam DG, Stroke 2010 41 6 1193 1199 10.1161/STROKEAHA.110.577973 20413738
39. Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke a 10-year follow-Up of 6584 men and women: the Tromsø study. Mathiesen EB, Johnsen SH, Wilsgaard T, Bønaa KH, Løchen M, Njølstad I, Stroke 2011 42 4 972 978 10.1161/STROKEAHA.110.589754 21311059
40. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men a 6-year follow-up study of 6226 persons: the Tromsø study. Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Løchen M, Njølstad I, Arnesen E, Stroke 2007 38 11 2873 2880 10.1161/STROKEAHA.107.487264 17901390
41. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Inaba Y, Chen JA, Bergmann SR, Atherosclerosis 2012 220 1 128 133 10.1016/j. atherosclerosis.2011.06.044 21764060
42. Artery-related differences in atherosclerosis expression implications for atherogenesis and dynamics in intima-media thickness. Dalager S, Paaske WP, Kristensen IB, Laurberg JM, Falk E, Stroke 2007 38 10 2698 2705 10.1161/STROKEAHA.107.486480 17761918
43. Atherosclerotic lesions are more frequent in femoral arteries than in carotid arteries independent of increasing number of risk factors. Kröger K, Kucharczik A, Hirche H, Rudofsky G, Angiology 1999 50 8 649 654 10.1177/000331979905000805 10451232
44. Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years the Asklepios Study. Langlois MR, Rietzschel ER, De Buyzere ML, De Bacquer D, Bekaert S, Blaton V, De Backer GG, Gillebert TC, Arterioscler Thromb Vasc Biol 2008 28 8 1563 1568 10.1161/ATVBAHA.108.167346 18511698
45. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Nakanishi N, Takatorige T, Fukuda H, Shirai K, Li W, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K, Diabetes Res Clin Pract 2004 64 1 59 10.1016/j.diabres.2003.10.001 15036828
46. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB, Circulation 2005 112 20 3066 3072 10.1161/CIRCULATIONAHA.105.539528 16275870
47. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities-cross-sectional study of the general population. Azevedo A, Bettencourt P, Almeida PB, Santos AC, Abreu-Lima C, Hense H, Barros H, BMC cardiovascular disorders 2007 7 1 17 10.1186/1471-2261-7-17 17555566
48. The metabolic syndrome is not a sensible tool for predicting the risk of coronary heart disease. Woodward M, Tunstall-Pedoe H, European Journal of Cardiovascular Prevention & Rehabilitation 2009 16 2 210 214 10.1097/HJR.0b013e3283282f8d 23949321
49. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS). Sone H, Tanaka S, Iimuro S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Ito H, Ohashi Y, J Atheroscler Thromb 2009 16 380 387 10.5551/jat.No117 19672033
50. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The three-City (3C) Study. Rachas A, Raffaitin C, Barberger-Gateau P, Helmer C, Ritchie K, Tzourio C, Amouyel P, Ducimetière P, Empana J, Heart 2012 98 8 650 655 10.1136/heartjnl-2011-301185 22505463
51. Metabolic syndrome vs. its components for prediction of cardiovascular mortality: a cohort study in Chinese elderly adults. Sun D, Wang J, Jiang B, Li L, Li L, Wu L, Wu H, He Y, Journal of Geriatric Cardiology 2012 9 2 123 10.3724/SP.J.1263.2012.01172 22916057
52. The metabolic syndrome: time to get off the merry-go-round? Reaven GM, J Intern Med 2011 269 2 127 136 10.1111/j.1365-2796.2010.02325.x 21129047
53. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report. National Institutes of Health, Obes Res 1998 6 Suppl. 2 I-209S